STEM Saves Lives
STEM Saves Lives Event to Highlight Biopharmaceutical Industry Support of STEM Education
This video is best viewed in browsers Chrome or Firefox
On Wednesday, January 22, 2014, U.S. News & World Report and the Pharmaceutical Research and Manufacturers of America (PhRMA) will jointly present STEM Saves Lives, a half-day forum about building a 21st century workforce educated in science, technology, engineering and math (STEM) to maintain global competitiveness in biomedical research and deliver medical advances to patients.
Bringing together top-level professionals from the STEM community, academia and the biopharmaceutical sector, STEM Saves Lives will feature:
- A CEO's perspective from John C. Lechleiter, Ph.D., Chairman, President and CEO of Eli Lilly and Company, and John J. Castellani, President and CEO, PhRMA.
- The release of a new Battelle Technology Partnership Practice report on the biopharmaceutical industry's efforts to improve STEM education in the United States.
- A panel of STEM champions from Amgen Inc., Cubist Pharmaceuticals, Inc., Citizen Schools and the Education Development Center (EDC).
- Keynote remarks by Dr. Mae Jemison, national advocate for Bayer’s Making Science Make Sense program. In addition to being a doctor, engineer, academic and entrepreneur, Dr. Jemison spent six years with NASA as an astronaut, during which time she became the first woman of color to go into space.
Please join us at the National Press Club in Washington, DC, on Wednesday, January 22, 2014 from 9:00 am to 12:30 pm for this exciting event.
To register, please email us at email@example.com.
Read the post "Coming Together to Address a National Problem: STEM Education," the latest from the PhRMA blog. Learn More
The initiative provides a platform for biopharmaceutical company scientists to inspire grade school students to enter STEM fields. Learn More
Page last updated 1/7/14 at 1:05 PM EST